IS4274A - Imidazopyridine compounds for use in the treatment of gastrointestinal disorders - Google Patents

Imidazopyridine compounds for use in the treatment of gastrointestinal disorders

Info

Publication number
IS4274A
IS4274A IS4274A IS4274A IS4274A IS 4274 A IS4274 A IS 4274A IS 4274 A IS4274 A IS 4274A IS 4274 A IS4274 A IS 4274A IS 4274 A IS4274 A IS 4274A
Authority
IS
Iceland
Prior art keywords
treatment
gastrointestinal disorders
imidazopyridine compounds
imidazopyridine
compounds
Prior art date
Application number
IS4274A
Other languages
Icelandic (is)
Inventor
Birgitta Briving Carin
Peter Nordberg Mats
Ingemar Starke Carl
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4274A publication Critical patent/IS4274A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS4274A 1994-04-11 1995-03-20 Imidazopyridine compounds for use in the treatment of gastrointestinal disorders IS4274A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9401197A SE9401197D0 (en) 1994-04-11 1994-04-11 Active compounds

Publications (1)

Publication Number Publication Date
IS4274A true IS4274A (en) 1995-10-12

Family

ID=20393591

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4274A IS4274A (en) 1994-04-11 1995-03-20 Imidazopyridine compounds for use in the treatment of gastrointestinal disorders

Country Status (6)

Country Link
AU (1) AU2270695A (en)
IL (1) IL113263A0 (en)
IS (1) IS4274A (en)
SE (1) SE9401197D0 (en)
WO (1) WO1995027714A1 (en)
ZA (1) ZA952860B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1257505A (en) * 1997-05-28 2000-06-21 比克·古尔顿·劳姆贝尔格化学公司 Fused dihydropyrans
CZ292335B6 (en) 1998-09-23 2003-09-17 Altana Pharma Ag Tetrahydropyridoethers, their use and pharmaceutical preparation in which they are comprised
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
CA2404460A1 (en) * 2000-03-29 2001-10-04 Altana Pharma Ag Alkylated imidazopyridine derivatives
CA2404477A1 (en) * 2000-03-29 2001-10-04 Altana Pharma Ag Tricyclic imidazopyridines
KR20020082494A (en) 2000-03-29 2002-10-31 알타나 파마 아게 Pyrano[2,3-c]imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders
MXPA02009551A (en) * 2000-03-29 2004-05-14 Altana Pharma Ag Prodrugs of imidazopyridine derivatives.
CN1692113A (en) 2000-10-25 2005-11-02 奥坦纳医药公司 Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (en) 2000-12-07 2007-09-25 Алтана Фарма Аг Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix
CA2452801A1 (en) * 2001-08-03 2003-02-27 Altana Pharma Ag Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
EP1417208A1 (en) * 2001-08-03 2004-05-12 ALTANA Pharma AG Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
ATE297931T1 (en) * 2001-08-10 2005-07-15 Altana Pharma Ag TRICYCLIC IMIDAZOPYRIDINES
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
AU2003254282A1 (en) 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
WO2004087701A1 (en) 2003-04-04 2004-10-14 Altana Pharma Ag Cyclic benzimidazoles
CA2549860A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
EP1735318A2 (en) * 2004-03-17 2006-12-27 Altana Pharma AG 7h-8,9-dihydro-pyrano(2,3-c)imidazo(1,2a)pyridine derivatives and their use as gastric acid secretion inhibitors
WO2007141253A1 (en) * 2006-06-07 2007-12-13 Nycomed Gmbh Process for the production of intermediates for the preparation of tricyclic imidazopyridines
MX2009004475A (en) 2006-10-27 2009-08-12 Univ Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same.
EP2252274A4 (en) 2008-02-20 2011-05-11 Univ Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines

Also Published As

Publication number Publication date
ZA952860B (en) 1996-01-12
IL113263A0 (en) 1995-10-31
WO1995027714A1 (en) 1995-10-19
SE9401197D0 (en) 1994-04-11
AU2270695A (en) 1995-10-30

Similar Documents

Publication Publication Date Title
IS4274A (en) Imidazopyridine compounds for use in the treatment of gastrointestinal disorders
DK1047428T3 (en) Use of morpholinol in the treatment of sexual disorders
NO996483D0 (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
IS5113A (en) Use of CB1 antagonists for the treatment of craving disorders
EE200100480A (en) Xenon for use in the treatment of nerve poisoning
EE04390B1 (en) Topical preparation for the treatment of dermatological conditions
IS5921A (en) Substitute Benzopyran analogues for use in the treatment of inflammation
KR960702787A (en) Improved polishing pads and methods for their use
EE04190B1 (en) Use of substituted benzopyran derivatives for the treatment of inflammation
PT752870E (en) USING MYCOBACTERIUM FOR THE TREATMENT OF TUMORS
DE69503634D1 (en) STRUCTURE FOR HOLDING THE ANKLE
NO991459D0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
ITMI981984A0 (en) DEVICE FOR THE HEAT TREATMENT OF PARTS
DE69515779D1 (en) Grinding device
BR9712030A (en) Use of benzopyranes for the treatment of neurological disorders
DK0904070T3 (en) Use of the buckminster fuller for the treatment of neurotoxic lesions
NO20012612D0 (en) Isonipecotamides for the treatment of integrin-mediated disorders
FI952953A (en) Substances for the treatment of metabolic skeletal disorders
NO993549L (en) Imino-aza-anthracycline derivatives for the treatment of amyloidosis
IT1299630B1 (en) CONNECTION DEVICE FOR THE CONNECTION OF TWO BODIES
DK1011678T3 (en) Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
IS5324A (en) (S) 2-Methylamino-2-phenyl-n-butyl 3,4,5-trimethoxy-benzoate, its use in the treatment of chronic pain
TR199501530A1 (en) Kit for use in the therapeutic cycle in the treatment of osteoporosis.
IS5855A (en) Alginate capsules for use in the treatment of brain tumors
NO20002567D0 (en) Method and composition to improve the adhesive device